Welcome to our dedicated page for ChipMOS TECHNOLOGIES news (Ticker: $IMOS), a resource for investors and traders seeking the latest updates and insights on ChipMOS TECHNOLOGIES stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ChipMOS TECHNOLOGIES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ChipMOS TECHNOLOGIES's position in the market.
ChipMOS Technologies Inc. reported a 17.7% increase in revenue for the first quarter of 2024 compared to the same period in 2023. Gross margin expanded to 14.2% from 12.4% in the first quarter of 2023. Net earnings more than doubled to NT$0.60 per basic common share. The company has a strong financial position with NT$12,164.6 million in cash and cash equivalents. A dividend of NT$1.8 per common share is pending shareholder approval at the May 2024 AGM.